Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200064654Phase 4Not yet recruiting
Phase 4, randomised trial of oxycodone in nephrolithiasis (2 arms), sponsored by Jiangmen Central Hospital. Primary endpoints: Blood pressure, Heart rate and 4 more. Planned start Jul 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200064654.